These mechanisms support cancer cell migration and blood vessel development within the tumor, making ANGPTL6 a potential therapeutic target in AFPGC and reinforcing AFP’s value as a prognostic biomarker in this rare malignancy [71]. The gene discussed is AFP; the disease is cancer.